Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HME1 | Ulixertinib | 0.031622777 | 0.6915 | 0.06603 |
| HME1 | Ulixertinib | 0.031622777 | 0.5799 | 0.12480 |
| HME1 | Ulixertinib | 0.031622777 | 0.6779 | 0.06090 |
| HME1 | Ulixertinib | 0.1 | 0.6097 | 0.09245 |
| HME1 | Ulixertinib | 0.1 | 0.6889 | 0.10196 |
| HME1 | Ulixertinib | 0.1 | 0.8481 | 0.02751 |
| HME1 | Ulixertinib | 0.316227766 | 0.3533 | 0.20483 |
| HME1 | Ulixertinib | 0.316227766 | 0.3739 | 0.13322 |
| HME1 | Ulixertinib | 0.316227766 | 0.3030 | 0.20937 |
| HME1 | Ulixertinib | 1.0 | 0.3305 | 0.20358 |
| HME1 | Ulixertinib | 1.0 | 0.3348 | 0.17489 |
| HME1 | Ulixertinib | 1.0 | 0.2858 | 0.20182 |
| HME1 | Ulixertinib | 3.16227766 | 0.1488 | 0.29887 |
| HME1 | Ulixertinib | 3.16227766 | 0.1024 | 0.30866 |
| HME1 | Ulixertinib | 3.16227766 | 0.1683 | 0.30606 |
| HME1 | Ulixertinib | 10.0 | 0.0167 | 0.37968 |
| HME1 | Ulixertinib | 10.0 | 0.0078 | 0.37986 |
| HME1 | Ulixertinib | 10.0 | -0.0098 | 0.44452 |
| HME1 | Alvocidib | 0.0001 | 1.0384 | -0.01388 |
| HME1 | Alvocidib | 0.0001 | 0.9696 | 0.01584 |
| HME1 | Alvocidib | 0.0001 | 0.9954 | -0.01718 |
| HME1 | Alvocidib | 0.000316228 | 0.9879 | -0.00336 |
| HME1 | Alvocidib | 0.000316228 | 0.8529 | 0.03299 |
| HME1 | Alvocidib | 0.000316228 | 0.9712 | -0.00217 |
| HME1 | Alvocidib | 0.001 | 0.9573 | 0.01999 |